Venus Remedies P/E Ratio
Venus Remedies P/E ratio. Venus Remedies (VENUSREM) P/E ratio is 16.5 (Moderate), EPS (TTM) ₹76.90, current price ₹1501.60 on NSE vs historical average P/E of 12.28 (80.0th percentile) — Moderate - Fairly valued. For live price, revenue and the complete fundamental profile, see Venus Remedies screener.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
VENUSREM P/E Ratio — Valuation Signal & Historical Context
Venus Remedies P/E 16.5 vs historical average 12.28, range 6.96–18.69 — signal: Fairly Valued. Also explore VENUSREM share price data to track price trends across different timeframes.
- Current PE is 34.3% above historical average
- Trading at discount to sector average PE of 52.33
Venus Remedies P/E Ratio Historical Trend
VENUSREM annual price-to-earnings ratio — 5 years, EPS and year-end price. Current P/E 16.5 vs historical average 12.28. Check Venus Remedies networth to track the company's total market size over time.
VENUSREM Historical P/E Ratio — EPS, Year-End Price & Valuation
Venus Remedies annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 8.11 | 57.09 | ₹462.75 | NSE | Low |
| 2024 | 12.28 | 26.07 | ₹320.15 | BSE | Low |
| 2023 | 18.69 | 21.72 | ₹405.95 | BSE | Moderate |
| 2022 | 15.38 | 11.78 | ₹181.15 | BSE | Moderate |
| 2021 | 6.96 | 58.85 | ₹409.60 | BSE | Low |
VENUSREM vs Healthcare Peers — P/E Ratio Comparison
Venus Remedies P/E 16.5 vs Healthcare average 52.33, median 29.6 — range 2.0–733.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |